Suppr超能文献

基因型与口腔癌风险的关联。

Association of Genotypes With Oral Cancer Risk.

机构信息

Department of Otorhinolaryngology, China Medical University Hospital, Taichung, Taiwan, R.O.C.

Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.

出版信息

In Vivo. 2022 Nov-Dec;36(6):2669-2677. doi: 10.21873/invivo.13002.

Abstract

BACKGROUND/AIM: The over-expression of enhancer of zeste homolog 2 (EZH2) protein is found in oral cancer tissues. However, the genetic role of the enhancer of EZH2 in the etiology of oral cancer is unknown. The aim of this study was to evaluate the association of EZH2 genotypes with oral cancer risk among Taiwanese.

MATERIALS AND METHODS

Three polymorphic variants of EZH2, rs887569 (C to T), rs41277434 (A to C), and rs3757441 (T to C), were analyzed regarding their association with oral cancer risk among 958 oral cancer patients and the same number of healthy controls by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). In addition, the interaction of EZH2 rs887569, rs41277434, and rs3757441 genotypes with personal behaviors such as smoking, alcohol drinking, and betel quid chewing were also examined.

RESULTS

The EZH2 genotypes rs887569, rs41277434, and rs3757441, were not significantly associated with oral cancer risk (p for trend=0.1735, 0.5658, and 0.4606, respectively). The analysis of allelic frequency distribution also supported the findings that the variant alleles at EZH2 rs887569, rs41277434, and rs3757441 may not serve as determinants of oral cancer risk (all p>0.05). There was no interaction between EZH2 rs887569, rs41277434, or rs3757441 genotypes with personal smoking, alcohol drinking or betel quid chewing behaviors.

CONCLUSION

EZH2 genotypes cannot predict oral cancer risk in Taiwan.

摘要

背景/目的:在口腔癌组织中发现增强子的 EZH2 蛋白过表达。然而,EZH2 增强子在口腔癌病因学中的遗传作用尚不清楚。本研究旨在评估 EZH2 基因型与台湾人口腔癌风险的相关性。

材料和方法

通过聚合酶链反应-限制性片段长度多态性(PCR-RFLP)分析 EZH2 的三个多态性变体 rs887569(C 到 T)、rs41277434(A 到 C)和 rs3757441(T 到 C)与 958 例口腔癌患者和相同数量的健康对照者的口腔癌风险之间的关系。此外,还检查了 EZH2 rs887569、rs41277434 和 rs3757441 基因型与个人行为(如吸烟、饮酒和咀嚼槟榔)之间的相互作用。

结果

EZH2 基因型 rs887569、rs41277434 和 rs3757441 与口腔癌风险无显著相关性(趋势检验 p 值分别为 0.1735、0.5658 和 0.4606)。等位基因频率分布的分析也支持了以下发现,即 EZH2 rs887569、rs41277434 和 rs3757441 的变异等位基因可能不是口腔癌风险的决定因素(均 p>0.05)。EZH2 rs887569、rs41277434 或 rs3757441 基因型与个人吸烟、饮酒或咀嚼槟榔行为之间无相互作用。

结论

EZH2 基因型不能预测台湾人口腔癌的风险。

相似文献

1
Association of Genotypes With Oral Cancer Risk.
In Vivo. 2022 Nov-Dec;36(6):2669-2677. doi: 10.21873/invivo.13002.
2
Association of Enhancer of Zeste 2 (EZH2) Genotypes with Bladder Cancer Risk in Taiwan.
Anticancer Res. 2016 Sep;36(9):4509-14. doi: 10.21873/anticanres.10997.
3
Effects of EZH2 polymorphisms on susceptibility to and pathological development of hepatocellular carcinoma.
PLoS One. 2013 Sep 10;8(9):e74870. doi: 10.1371/journal.pone.0074870. eCollection 2013.
4
Association of Caspase-8 Genotypes With Oral Cancer Risk in Taiwan.
In Vivo. 2019 Jul-Aug;33(4):1151-1156. doi: 10.21873/invivo.11585.
5
Association of Matrix Metalloproteinase-7 Genotypes to the Risk of Oral Cancer in Taiwan.
Anticancer Res. 2018 Apr;38(4):2087-2092. doi: 10.21873/anticanres.12448.
6
The Contribution of Interleukin-12A Genotypes to Oral Cancer Risk in Taiwanese.
Anticancer Res. 2020 Jul;40(7):3707-3712. doi: 10.21873/anticanres.14359.
7
Interaction of Interleukin-16 Genotypes With Betel Quid Chewing Behavior on Oral Cancer in Taiwan.
In Vivo. 2020 Jul-Aug;34(4):1759-1764. doi: 10.21873/invivo.11969.
8
The Contribution of PDCD6 Polymorphisms to Oral Cancer Risk.
Cancer Genomics Proteomics. 2022 Jul-Aug;19(4):456-463. doi: 10.21873/cgp.20332.
9
Analysis of EZH2 Genetic Variants on Triple-Negative Breast Cancer Susceptibility and Pathology.
Int J Med Sci. 2022 May 29;19(6):1023-1028. doi: 10.7150/ijms.71931. eCollection 2022.
10
Impact of EZH2 polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic features.
PLoS One. 2014 Apr 1;9(4):e93635. doi: 10.1371/journal.pone.0093635. eCollection 2014.

本文引用的文献

1
The Contribution of Flap Endonuclease 1 Genotypes to Oral Cancer Risk.
Anticancer Res. 2022 Sep;42(9):4329-4335. doi: 10.21873/anticanres.15933.
2
The Contribution of Interleukin-8 Rs4073 Genotypes to Triple Negative Breast Cancer Risk in Taiwan.
Anticancer Res. 2022 Aug;42(8):3799-3806. doi: 10.21873/anticanres.15870.
4
Significant Contribution of Interleukin-18 Genotypes to Lung Cancer Risk in Taiwanese.
Anticancer Res. 2022 Jul;42(7):3381-3387. doi: 10.21873/anticanres.15825.
5
The Contribution of PDCD6 Polymorphisms to Oral Cancer Risk.
Cancer Genomics Proteomics. 2022 Jul-Aug;19(4):456-463. doi: 10.21873/cgp.20332.
6
Lip, Oral Cavity and Pharyngeal Cancer Burden in the European Union from 1990-2019 Using the 2019 Global Burden of Disease Study.
Int J Environ Res Public Health. 2022 May 27;19(11):6532. doi: 10.3390/ijerph19116532.
7
Burden of oral cancer in Asia from 1990 to 2019: Estimates from the Global Burden of Disease 2019 study.
PLoS One. 2022 Mar 24;17(3):e0265950. doi: 10.1371/journal.pone.0265950. eCollection 2022.
8
Cancer statistics, 2022.
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
9
Interaction of DNA Repair Gene XPC With Smoking and Betel Quid Chewing Behaviors of Oral Cancer.
Cancer Genomics Proteomics. 2021 May-Jun;18(3 Suppl):441-449. doi: 10.21873/cgp.20270.
10
The noncanonical role of EZH2 in cancer.
Cancer Sci. 2021 Apr;112(4):1376-1382. doi: 10.1111/cas.14840. Epub 2021 Feb 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验